Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer's disease

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 3, 2013, Pages 258-262

  Cacciapuoti, Federico ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Alzheimer's disease (AD); Atherosclerosis; DNA hypomethylation; Homocysteine; Mild cognitive impairment; Vitamins B6 12 and folates SUPPL.ementation

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CYSTEINE; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PRESENILIN 1; S ADENOSYLMETHIONINE; VITAMIN B GROUP;

AGING; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DESULFURIZATION; HEART INFARCTION; HYPERHOMOCYSTEINEMIA; METHYLATION; MILD COGNITIVE IMPAIRMENT; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; COGNITION; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; VITAMIN B COMPLEX;

EID: 84884815979     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0856-x     Document Type: Article

References (53)

1. Bostom AG, Silbershatz H, Rosenberg IH, Selubh J, D'Agostino RB, Wolf PA et al (1999) Nonfasting plasma total homocysteine levels and all cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159:1077-1080
2. Refsum H, Ueland PM, Nygard O, Vollset SE (1998) Homocysteine and cardiovascular disease. Annu Rev Med 49:31-62
3. Kalmjn S, Launer IJ, Lindermans J, Bots ML, Hofman A, Breteler MM (1999) Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam study. Am J Epidemol 150:283-389
4. Morris MS (2003) Homocysteine and Alzheimer's disease. Lancet Neurol 2:425-428
5. Van Dam F, Van Gool WA (2009) Hyperhomocysteinemia and Alzheimer's disease: A systematic review. Arch Gerontol Geriatr 48:425-430
6. Kamath AF, Chauhan AK, Kisuka J, Dole VS, Loscalzo J, Handy DE, Wagner DD (2006) Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood 107:591-593
7. Mudher A, Lovestone S (2002) Alzheimer's disease - do tauists and Baptists shake hand? Trends Neurosci 25:22-26
8. Matthias D, Becker CH, Riezler R, Kindling PH (1996) Homocysteine induced atherosclerosis-like alterations of the aorta in normotensive and hypertensive rats following of high doses of methionine. Atherosclerosis 122:201-216
9. Tsai JC, Perrella MA, Yoshizumi M et al (1994) Promotion of vascular muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 91:6369-6373
10. Durand P, Lussier-Cacan S, Blache D (1997) Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis and macrophage-derived tissue factor in rats. FASEB J 11:1157-1168
11. Zhang RA, Ma M, Zhu H, Ling W (2004) Mild hyperhomocysteinemia induced by feeding rat diets in methionine or deficient folate promotes early atherosclerosis inflammatory processes. J Nutr 134:825-830
12. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC et al (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The vitamin intervention for stroke prevention (VISP) randomized controlled trial. J Am Med Assoc 291:565-575
13. Lonne E, Yusuf S, Arnold MJ, Sheridan P, Pogue J et al (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567-1577
14. Bonna KH, Njolstad I. Ueland PM, Schimer H, Tverdal A et al (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578-1588
15. Bazzano LA, Reynolds K, Holder KN, He J (2006) Effect of folic acid SUPPL.ementation on risk of cardiovascular disease. JAMA 296:720-726
16. 12 vs. placebo on mortality and major morbidity in myocardial survivors. A randomized trial. JAMA 303:486-494
17. Jamaluddin MD, Chen I, Yang F, Jiang X, Jan M, Schafer AI, Durante W, Yang X, Wang H (2007) Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 110:3848-3855
18. Anello G, Gueant-Rodriguez P, Bosco N et al (2004) Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. NeuroReport 15:859-861
19. Miller JW (2000) Homocysteine, Alzheimer's disease, and cognitive function. Nutrition 16:675-677
20. Dwyer BE, Raina AK, Perry G, Smith MA (2004) Homocysteine and Alzheimer's disease: A modifiable risk? Free Radic Biol Med 36:1471-1475
21. Perna AF, Ingrosso D. De Santo N (2003) Homocysteine and oxidative stress. Amino Acids 25:409-412
22. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699
23. Corder EH, Saunders AM, Risch NJ et al (1994) Protective effect of apolipoprotein E type 2 allele for late-onset Alzheimer's disease. Nat Gen 7:180-184
24. Mingawa H, Watanabe A, Akatsu H, Adachi K, Ohtsuka C, Terayama Y et al (2010) Homocysteine, another risk factor for Alzheimer disease impairs apolipoprotein E3 function. J Biol Chem 285:38382-38388
25. Kruman II, Kumartavel TS, Lohani A et al (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 70:694-702
26. Zhang CE, Wei W, Liu YH, Peng JH, Tian Q, Liu GP et al (2009) Hyperhomocysteinemia increases β-amyloid by enhancing expression of γ-secretase on phosphorylation of amyloid precursor protein in rat brain. Am J Pathol 174:1481-1491
27. Selkoe DJ (1994) Alzheimer's disease: A central role for amyloid. J Neuropathol Exp Neurol 53:438-447
28. Mattson MP, Tomaselli HJ, Rydel RE (1993) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 621:35-49
29. Harada J, Sugimoto M (1999) Activation of caspase-3 in β-Amyloid induced apoptosis of cultured rat cortical neurons. Brain Res 842:311-323
30. Busciglio J, Lorenzo A, Yeh J, Yanker BA (1995) β-amyloid fibrils induce tau phosphorylation and loss of mitochondrial binding. Neuron 14:879-888
31. Wang X, Su B, Siedlak SL, Moreira PI, Fujoka H, Wang Y et al (2008) Amyloid-β over-production causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 105:19318-19323
32. Nprins ND, den Heijer T, Hofman A, Koudstaal PJ, Clarke R et al (2002) Homocysteine and cognitive function in the elderly. The Rotterdam Scan Study. Neurology 59:1375-1380
33. Budge M, Johnson C, Hogenvost E, de Jeger C, Milkain E, Ieveran SD, Barnetson C et al (2000) Plasma total homocysteine and cognitive performance in a volunteer elderly population. Ann NY Acad Sci 903:407-410
34. Oulhaj A, Refsum H, Beaumont H, Williams J, King E, Jacoby R, Smith AD (2010) Homocysteine as predictor of cognitive decline in Alzheimer disease. Int J Geriatr Psychiatry 25:82-90
35. Almeida CC, Brentani HP, Forlenza OV, Diniz BS (2012) Serum folic acid is reduced in patients with Alzheimer's disease. Rev Psiquiatr Clin 39:90-93
36. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni I (2001) Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 56:1188-1194
37. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N et al (2005) Homocysteine and folate as risk factors for dementia and Alzheimer's disease. Am J Clin Nutr 82:636-643
38. Nicolia V, Fuso A, Cavallaro RA, Di Luzio A, Scarpa S (2010) B vitamin deficiency promotes tau phosphorylation through regulation of GSK 3-beta and PP2A. J Alzheimer Dis 19:895-907
39. Yu NK, Back SH, Kaang BK (2011) DNA methylation-mediated control of learning and memory. Mol Brain 4:5
40. Jung AY, Smulders Y, Verhoef P, Kok FJ, Blom H, Kok RM, Kampman E, Durga J (2011) No effect of folic acid in men and women with moderately elevated homocysteine. PLoS One 6:e24976. doi: 10.1371/journal.pone.0024976
41. Durga J, van Boxel MP, Schouten EG, Kok FJ, Jolles J et al (2007) Effect of 3-years folic acid SUPPL.ementation on cognitive function in older adults in the FACIT trial: A randomized, double blind, controlled trial. Lancet 369:208-216
42. Mc Mahon JA, Green TJ, Skeaff CM, Knight RG, Mann JL et al (2006) A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 354:2764-2772
43. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G et al (2010) Homocysteine-lowering by vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS One 5:212244. doi: 10.1371/journal.pone.0012244
44. Mirashi EH et al (2003) Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging. J Nutr Health Aging 7:160-165
45. Serot JM, Barbè F, Arming E, Bottiglieri T, Frank P, Montoghe P, Nicolas P (2005) Homocysteine and methylmalonic acid concentration in cerebro-spinal fluid: Relation with age and Alzheimer's disease. J Neurosurg Psychiatry 76:1585-1587
46. Fuso A, Nicolia RA, Cavallaro L, Ricceri F, D'Anselmi P, Coluccia G, Calamandrei G, Scarpa S (2008) B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine depletes brain S-adenosylmethionine and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol Cell Neurosci 37:731-746
47. Ujiie M, Dickstein DL, Carlow DA, Jeffries WA (2003) Blood-brain-barrier permeability precedes senile plaques formation in an Alzheimer disease model. Microcirculation 10:463-470
48. Arshavasky YI (2010) Why Alzheimer's disease starts with a memory impairment: neurophysiological insight. J Alzheimer Dis 20:5-16
49. Tchantchou F, Graves M, Falcone D, Shea TB (2008) S-adenosyl methionine mediates glutathione efficacy by increasing glutathione S-transferase activity: Implications for S-adenosylmethionine as a neuroprotective dietary activity SUPPL.ement. J Alzheimer Dis 14:323-328
50. Boldyvrev AA, Johnson P (2007) Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer's disease. J Alzheimer Dis 11:219-228
51. den Heijer T et al (2003) Homocysteine and brain atrophy on MRI of non-demanded elderly. Brain 126:170-175
52. Williams JH et al (2002) Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age Aging 31:440-444
53. Kim SR et al (2009) Plasma total homocysteine levels are not associated with medial temporal lobe atrophy, but with white matter changes in Alzheimer's disease. J Clin Neurol 5:85-90